Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 8/20 | 0.54 |
| ▸ | LPAR2 | Q9HBW0 | 6/20 | 0.54 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.54 |
| ▸ | CDC25A | P30304 | 4/20 | 0.42 |
| ▸ | CDC25B | P30305 | 4/20 | 0.42 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.39 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL215088 | 0.93 | LPAR3 (0.57) | LPAR3LPAR2LPAR1CDC25ACDC25B | |
| SCHEMBL506267 | 0.91 | LPAR3 (0.61) | LPAR3LPAR2LPAR1CDC25ACDC25B | |
| SCHEMBL1100940 | 0.91 | LPAR3 (0.61) | LPAR3LPAR2LPAR1CDC25ACDC25B | |
| SCHEMBL31104703 | 0.91 | LPAR3 (0.61) | LPAR3LPAR2LPAR1CDC25ACDC25B | |
| SCHEMBL346631 | 0.91 | LPAR3 (0.61) | LPAR3LPAR2LPAR1CDC25ACDC25B | |
| SCHEMBL10437947 | 0.91 | LPAR3 (0.55) | LPAR3LPAR2LPAR1CDC25ACDC25B | |
| SCHEMBL945571 | 0.91 | LPAR3 (0.61) | LPAR3LPAR2LPAR1CDC25ACDC25B | |
| SCHEMBL9659858 | 0.91 | LPAR3 (0.61) | LPAR3LPAR2LPAR1CDC25ACDC25B | |
| SCHEMBL20875987 | 0.91 | LPAR3 (0.61) | LPAR3LPAR2LPAR1CDC25ACDC25B | |
| SCHEMBL30268607 | 0.91 | LPAR3 (0.61) | LPAR3LPAR2LPAR1CDC25ACDC25B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111363518-B | Preparation method of phosphate drag reducer and application of phosphate drag reducer in gas pipeline | 辽宁大学 | 2023-09-15 | — | — | CN | claimed |
| CN-110833835-B | Preparation method of carbon-coated metal particle anchored nano catalytic material | 广西大学 | 2023-06-09 | — | — | CN | claimed |
| CN-111363518-A | Preparation method of phosphate drag reducer and application of phosphate drag reducer in gas pipeline | 辽宁大学 | 2020-07-03 | — | — | CN | claimed |
| US-12496335-B2 | Zika virus vaccine | CureVac SE (DE) | 2025-12-16 | — | — | US | disclosed |
| WO-2024122372-A1 | ELASTIC FIBER TREATMENT AGENT AND USE THEREOF | 松本油脂製薬株式会社 | 2024-06-13 | — | — | WO | disclosed |
| WO-2024090138-A1 | ELASTIC FIBER TREATMENT AGENT AND USE THEREOF | 松本油脂製薬株式会社 | 2024-05-02 | — | — | WO | disclosed |
| CN-111433177-B | Is used for preparing 1, 3-trichloro-4, 4-trifluoro-but-1-ene E) -1, 4-hexafluorobut-2-ene processes and intermediates | 科慕埃弗西有限公司 | 2024-04-16 | — | — | CN | disclosed |
| US-20240024453-A1 | ZIKA VIRUS VACCINE | CureVac SE (DE) | 2024-01-25 | — | — | US | disclosed |
| CN-111363518-B | Preparation method of phosphate drag reducer and application of phosphate drag reducer in gas pipeline | 辽宁大学 | 2023-09-15 | — | — | CN | disclosed |
| CN-112368349-B | Adhesive composition, preparation method thereof, adhesive sheet body containing adhesive composition and product | CJ第一制糖株式会社 | 2023-01-10 | — | — | CN | disclosed |
| CN-112368349-A | Adhesive composition for label, method for preparing the same, adhesive sheet comprising the same, and object comprising the adhesive sheet | CJ第一制糖株式会社 | 2021-02-12 | — | — | CN | disclosed |
| EP-2330675-B1 | SECONDARY BATTERY | NEC CORP (JP) | 2018-08-22 | — | — | EP | disclosed |
| CN-108291157-A | Selective hydrogenation using flow index | 切弗朗菲利浦化学公司 | 2018-07-17 | — | — | CN | disclosed |
| CN-107107049-A | Selective hydrogenation catalyst and its preparation and application | 切弗朗菲利浦化学公司 | 2017-08-29 | — | — | CN | disclosed |
| CN-103403950-A | Lithium ion battery | NEC ENERGY DEVICES LTD | 2013-11-20 | — | — | CN | disclosed |
| US-20120171542-A1 | SECONDARY BATTERY | NEC CORPORATION (JP) | 2012-07-05 | — | — | US | disclosed |
| US-20110159379-A1 | SECONDARY BATTERY | NEC CORPORATION (JP) | 2011-06-30 | — | — | US | disclosed |
| EP-2330675-A1 | SECONDARY BATTERY | NEC Corporation (JP) | 2011-06-08 | — | — | EP | disclosed |
| US-20060172201-A1 | Non-aqueous electrolyte and lithium secondary battery using the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2006-08-03 | — | — | US | disclosed |
| EP-1357628-A1 | NONAQUEOUS ELECTROLYTIC LIQUIDS AND LITHIUM SECONDARY BATTERY EMPLOYING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2003-10-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240024453-A1 | ZIKA VIRUS VACCINE | DDX5, STING1, MICA | LPAR3 1429/4885LPAR2 2266/4885LPAR1 2428/4885 |
| US-12496335-B2 | Zika virus vaccine | DDX5, STING1, MICA | LPAR3 1429/4885LPAR2 2266/4885LPAR1 2428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.